RegenETP, Inc. (RGTPQ)
OTCMKTS · Delayed Price · Currency is USD
0.1560
-0.0140 (-8.24%)
Inactive · Last trade price on Apr 16, 2025

RegenETP Company Description

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States.

The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services.

The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products.

The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023.

RegenETP, Inc. is headquartered in Salt Lake City, Utah.

RegenETP, Inc.
CountryUnited States
IndustryBiotechnology
SectorHealthcare
Employees43
CEORichard Hague

Contact Details

Address:
1960 South 4250 West
Salt Lake City, Delaware 84104
United States
Phone800 560 3983
Websitepolaritybio.com

Stock Details

Ticker SymbolRGTPQ
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code2836

Key Executives

NamePosition
Richard HaguePresident, Chief Executive Officer and Director
Nikolai Sopko M.D., Ph.D.Chief Operating Officer and Chief Scientific Officer
Rich HaerleVice President of Investor Relations and Strategy
Mark E. Lehman J.D.Chief Legal Officer
Angela ZieglerVice President of Marketing and Public Relations
Alain AdamVice President of Sales
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.Senior Vice President of Corporate Development and President of Contract Services
Ryan Mathis M.D.Chief Medical Officer
Kolby Day Esq.Senior Vice President of Manufacturing Operations